Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib is a promising treatment for alopecia areata.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

JAK inhibitors show promise for treating various skin diseases.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Upadacitinib may cause hair loss.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.